相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma
Xiaobin Wu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2022)
Resveratrol alleviates bleomycin-induced pulmonary fibrosis via suppressing HIF-1α and NF-κB expression
Zaiyan Wang et al.
Aging-US (2021)
Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy
Youzi Dong et al.
SCIENTIFIC REPORTS (2021)
Progress in the treatment of pulmonary fibrosis
Marlies Wijsenbeek
LANCET RESPIRATORY MEDICINE (2020)
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
Xiao Chen et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Beatriz Ballester et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
In Vivo Activation and Pro-Fibrotic Function of NF-κB in Fibroblastic Cells During Pulmonary Inflammation and Fibrosis Induced by Carbon Nanotubes
Jie Dong et al.
FRONTIERS IN PHARMACOLOGY (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
Caveolin-1-derived peptide limits development of pulmonary fibrosis
Amarnath Satheesh Marudamuthu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
Network-based Approaches in Pharmacology
Baptiste Boezio et al.
MOLECULAR INFORMATICS (2017)
Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
Gayathri Sathiyamoorthy et al.
SOUTHERN MEDICAL JOURNAL (2017)
Protective effect of 3-O-methyl quercetin and kaempferol from Semecarpus anacardium against H2O2 induced cytotoxicity in lung and liver cells
A. D. Naveen Kumar et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Kaempferol targets Krt-14 and induces cytoskeletal mineralization in osteoblasts: A mechanistic approach
Vikram Khedgikar et al.
LIFE SCIENCES (2016)
Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes
Shuang Chen et al.
MEDIATORS OF INFLAMMATION (2016)
Protective Effects of Kaempferol against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart via Antioxidant Activity and Inhibition of Glycogen Synthase Kinase-3β
Mingjie Zhou et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Kaempferol and inflammation: From chemistry to medicine
Kasi Pandima Devi et al.
PHARMACOLOGICAL RESEARCH (2015)
Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Induces Gene Expression of Anti-viral Proteins and Inhibits Neuraminidase Activity
Crystal Y. Q. Du et al.
PHYTOTHERAPY RESEARCH (2015)
Kaempferol Inhibits IL-1β-Stimulated, RANKL-mediated Osteoclastogenesis via Downregulation of MAPKs, c-Fos, and NFATc1
Won-Seok Lee et al.
INFLAMMATION (2014)
Quercetin Protects against Obesity-Induced Skeletal Muscle Inflammation and Atrophy
Ngoc Hoan Le et al.
MEDIATORS OF INFLAMMATION (2014)
Screening Active Components from Yu-Ping-Feng-San for Regulating Initiative Key Factors in Allergic Sensitization
Dandan Shen et al.
PLOS ONE (2014)
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Jinlong Ru et al.
JOURNAL OF CHEMINFORMATICS (2014)
Development of an SPE-HPLC-MS method for simultaneous determination and pharmacokinetic study of bioactive constituents of Yu Ping Feng San in rat plasma after oral administration
Tao Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Traditional Chinese medicine network pharmacology: theory, methodology and application
Li Shao et al.
CHINESE JOURNAL OF NATURAL MEDICINES (2013)
DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice
Nada Orsolic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
BisoGenet: a new tool for gene network building, visualization and analysis
Alexander Martin et al.
BMC BIOINFORMATICS (2010)
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo
Elena Tourkina et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
The role of fatty acids and caveolin-1 in tumor necrosis factor α-induced endothelial cell activation
Lei Wang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
Xiao Mei Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression
R Koslowski et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Mechanisms of pulmonary fibrosis
VJ Thannickal et al.
ANNUAL REVIEW OF MEDICINE (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor
B Razani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
分享论文
